> top > docs > PubMed:15630069 > annotations

PubMed:15630069 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
1319 0-7 ChemicalEntity denotes Glucose MESH:D005947
1320 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
1321 72-92 ChemicalEntity denotes antipsychotic agents MESH:D014150
1322 127-134 ChemicalEntity denotes glucose MESH:D005947
1323 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus MESH:D003920
1324 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
1325 320-340 ChemicalEntity denotes antipsychotic agents MESH:D014150
1326 408-415 ChemicalEntity denotes glucose MESH:D005947
1327 471-479 DiseaseOrPhenotypicFeature denotes diabetes MESH:D003920
1328 538-547 ChemicalEntity denotes clozapine MESH:D003024
1329 552-562 ChemicalEntity denotes olanzapine MESH:C076029
1330 568-579 ChemicalEntity denotes risperidone MESH:D018967
1331 619-626 ChemicalEntity denotes glucose MESH:D005947
1332 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
1333 772-779 ChemicalEntity denotes glucose MESH:D005947
1334 1069-1076 ChemicalEntity denotes glucose MESH:D005947
1335 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
1336 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder MESH:D011618
1337 1221-1230 ChemicalEntity denotes clozapine MESH:D003024
1338 1232-1242 ChemicalEntity denotes olanzapine MESH:C076029
1339 1247-1258 ChemicalEntity denotes risperidone MESH:D018967
1340 1329-1336 ChemicalEntity denotes glucose MESH:D005947
1341 1355-1362 ChemicalEntity denotes insulin MESH:D007328
1342 1430-1448 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333
1343 1454-1461 ChemicalEntity denotes glucose MESH:D005947
1344 1553-1572 ChemicalEntity denotes antipsychotic agent MESH:D014150
1345 1599-1608 ChemicalEntity denotes clozapine MESH:D003024
1346 1633-1643 ChemicalEntity denotes olanzapine MESH:C076029
1347 1665-1676 ChemicalEntity denotes risperidone MESH:D018967
1348 1693-1700 ChemicalEntity denotes insulin MESH:D007328
1349 1764-1773 ChemicalEntity denotes clozapine MESH:D003024
1350 1774-1784 ChemicalEntity denotes olanzapine MESH:C076029
1351 1785-1796 ChemicalEntity denotes risperidone MESH:D018967
1352 1835-1844 ChemicalEntity denotes clozapine MESH:D003024
1353 1849-1860 ChemicalEntity denotes risperidone MESH:D018967
1354 1889-1899 ChemicalEntity denotes olanzapine MESH:C076029
1355 1904-1915 ChemicalEntity denotes risperidone MESH:D018967
1356 2043-2052 ChemicalEntity denotes clozapine MESH:D003024
1357 2053-2063 ChemicalEntity denotes olanzapine MESH:C076029
1358 2064-2075 ChemicalEntity denotes risperidone MESH:D018967
1359 2105-2114 ChemicalEntity denotes clozapine MESH:D003024
1360 2119-2129 ChemicalEntity denotes olanzapine MESH:C076029
1361 2153-2171 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333
1362 2217-2228 ChemicalEntity denotes risperidone MESH:D018967
1363 2230-2239 ChemicalEntity denotes clozapine MESH:D003024
1364 2243-2254 ChemicalEntity denotes risperidone MESH:D018967
1365 2279-2289 ChemicalEntity denotes olanzapine MESH:C076029
1366 2293-2304 ChemicalEntity denotes risperidone MESH:D018967
1367 2377-2395 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333
1368 2462-2471 ChemicalEntity denotes clozapine MESH:D003024
1369 2472-2482 ChemicalEntity denotes olanzapine MESH:C076029
1370 2483-2494 ChemicalEntity denotes risperidone MESH:D018967
1371 2497-2506 ChemicalEntity denotes clozapine MESH:D003024
1372 2510-2521 ChemicalEntity denotes risperidone MESH:D018967
1373 2547-2557 ChemicalEntity denotes olanzapine MESH:C076029
1374 2561-2572 ChemicalEntity denotes risperidone MESH:D018967
1375 2649-2656 ChemicalEntity denotes glucose MESH:D005947
1376 2696-2705 ChemicalEntity denotes clozapine MESH:D003024
1377 2706-2716 ChemicalEntity denotes olanzapine MESH:C076029
1378 2717-2728 ChemicalEntity denotes risperidone MESH:D018967
1379 2767-2776 ChemicalEntity denotes clozapine MESH:D003024
1380 2781-2792 ChemicalEntity denotes risperidone MESH:D018967
1381 2822-2832 ChemicalEntity denotes olanzapine MESH:C076029
1382 2837-2848 ChemicalEntity denotes risperidone MESH:D018967
1383 2902-2911 ChemicalEntity denotes clozapine MESH:D003024
1384 2917-2927 ChemicalEntity denotes olanzapine MESH:C076029
1385 2965-2983 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333
1386 3002-3009 ChemicalEntity denotes glucose MESH:D005947
1387 3038-3049 ChemicalEntity denotes risperidone MESH:D018967
1388 3084-3093 ChemicalEntity denotes clozapine MESH:D003024
1389 3098-3108 ChemicalEntity denotes olanzapine MESH:C076029
1390 3130-3148 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-177 Sentence denotes Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
T2 178-189 Sentence denotes BACKGROUND:
T3 190-480 Sentence denotes While the incidence of new-onset diabetes mellitus may be increasing in patients with schizophrenia treated with certain atypical antipsychotic agents, it remains unclear whether atypical agents are directly affecting glucose metabolism or simply increasing known risk factors for diabetes.
T4 481-491 Sentence denotes OBJECTIVE:
T5 492-642 Sentence denotes To study the 2 drugs most clearly implicated (clozapine and olanzapine) and risperidone using a frequently sampled intravenous glucose tolerance test.
T6 643-650 Sentence denotes DESIGN:
T7 651-834 Sentence denotes A cross-sectional design in stable, treated patients with schizophrenia evaluated using a frequently sampled intravenous glucose tolerance test and the Bergman minimal model analysis.
T8 835-843 Sentence denotes SETTING:
T9 844-968 Sentence denotes Subjects were recruited from an urban community mental health clinic and were studied at a general clinical research center.
T10 969-1092 Sentence denotes Patients Fifty subjects signed informed consent and 41 underwent the frequently sampled intravenous glucose tolerance test.
T11 1093-1290 Sentence denotes Thirty-six nonobese subjects with schizophrenia or schizoaffective disorder, matched by body mass index and treated with either clozapine, olanzapine, or risperidone, were included in the analysis.
T12 1291-1313 Sentence denotes MAIN OUTCOME MEASURES:
T13 1314-1476 Sentence denotes Fasting plasma glucose and fasting serum insulin levels, insulin sensitivity index, homeostasis model assessment of insulin resistance, and glucose effectiveness.
T14 1477-1485 Sentence denotes RESULTS:
T15 1486-1678 Sentence denotes The mean +/- SD duration of treatment with the identified atypical antipsychotic agent was 68.3 +/- 28.9 months (clozapine), 29.5 +/- 17.5 months (olanzapine), and 40.9 +/- 33.7 (risperidone).
T16 1679-1940 Sentence denotes Fasting serum insulin concentrations differed among groups (F(33) = 3.35; P = .047) (clozapine>olanzapine>risperidone) with significant differences between clozapine and risperidone (t(33) = 2.32; P = .03) and olanzapine and risperidone (t(33) = 2.15; P = .04).
T17 1941-2340 Sentence denotes There was a significant difference in insulin sensitivity index among groups (F(33) = 10.66; P<.001) (clozapine<olanzapine<risperidone), with subjects who received clozapine and olanzapine exhibiting significant insulin resistance compared with subjects who were treated with risperidone (clozapine vs risperidone, t(33) = -4.29; P<.001; olanzapine vs risperidone, t(33) = -3.62; P = .001 [P<.001]).
T18 2341-2597 Sentence denotes The homeostasis model assessment of insulin resistance also differed significantly among groups (F(33) = 4.92; P = .01) (clozapine>olanzapine>risperidone) (clozapine vs risperidone, t(33) = 2.94; P = .006; olanzapine vs risperidone, t(33) = 2.42; P = .02).
T19 2598-2874 Sentence denotes There was a significant difference among groups in glucose effectiveness (F(30) = 4.18; P = .02) (clozapine<olanzapine<risperidone) with significant differences between clozapine and risperidone (t(30) = -2.59; P = .02) and olanzapine and risperidone (t(30) = -2.34, P = .03).
T20 2875-2887 Sentence denotes CONCLUSIONS:
T21 2888-3067 Sentence denotes Both nonobese clozapine- and olanzapine-treated groups displayed significant insulin resistance and impairment of glucose effectiveness compared with risperidone-treated subjects.
T22 3068-3170 Sentence denotes Patients taking clozapine and olanzapine must be examined for insulin resistance and its consequences.

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T2 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus 0005015
T3 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T4 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T5 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T6 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder 0005487

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T3 145-149 GeneOrGeneProduct denotes test
T1 63-71 GeneOrGeneProduct denotes atypical
T2 135-144 GeneOrGeneProduct denotes tolerance
T4 223-231 GeneOrGeneProduct denotes diabetes
T5 311-319 GeneOrGeneProduct denotes atypical
T6 353-360 GeneOrGeneProduct denotes unclear
T7 369-377 GeneOrGeneProduct denotes atypical
T8 459-470 GeneOrGeneProduct denotes factors for
T9 471-479 GeneOrGeneProduct denotes diabetes
T10 627-636 GeneOrGeneProduct denotes tolerance
T11 637-641 GeneOrGeneProduct denotes test
T12 780-789 GeneOrGeneProduct denotes tolerance
T13 790-794 GeneOrGeneProduct denotes test
T14 1077-1086 GeneOrGeneProduct denotes tolerance
T15 1087-1091 GeneOrGeneProduct denotes test
T16 1181-1196 GeneOrGeneProduct denotes body mass index
T17 1291-1295 GeneOrGeneProduct denotes MAIN
T18 1314-1321 GeneOrGeneProduct denotes Fasting
T19 1341-1348 GeneOrGeneProduct denotes fasting
T20 1355-1362 GeneOrGeneProduct denotes insulin
T21 1371-1378 GeneOrGeneProduct denotes insulin
T22 1430-1437 GeneOrGeneProduct denotes insulin
T23 1544-1552 GeneOrGeneProduct denotes atypical
T24 1679-1686 GeneOrGeneProduct denotes Fasting
T25 1693-1700 GeneOrGeneProduct denotes insulin
T26 1979-1986 GeneOrGeneProduct denotes insulin
T27 2153-2160 GeneOrGeneProduct denotes insulin
T28 2377-2384 GeneOrGeneProduct denotes insulin
T29 2537-2545 GeneOrGeneProduct denotes P = .006
T30 2965-2972 GeneOrGeneProduct denotes insulin
T31 3130-3137 GeneOrGeneProduct denotes insulin

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 63-71 GeneOrGeneProduct denotes atypical
T2 223-231 GeneOrGeneProduct denotes diabetes
T3 311-319 GeneOrGeneProduct denotes atypical
T4 353-360 GeneOrGeneProduct denotes unclear
T5 369-377 GeneOrGeneProduct denotes atypical
T6 471-479 GeneOrGeneProduct denotes diabetes
T7 1181-1196 GeneOrGeneProduct denotes body mass index
T8 1291-1295 GeneOrGeneProduct denotes MAIN
T9 1355-1362 GeneOrGeneProduct denotes insulin
T10 1371-1378 GeneOrGeneProduct denotes insulin
T11 1430-1437 GeneOrGeneProduct denotes insulin
T12 1544-1552 GeneOrGeneProduct denotes atypical
T13 1693-1700 GeneOrGeneProduct denotes insulin
T14 1979-1986 GeneOrGeneProduct denotes insulin
T15 2153-2160 GeneOrGeneProduct denotes insulin
T16 2377-2384 GeneOrGeneProduct denotes insulin
T17 2965-2972 GeneOrGeneProduct denotes insulin
T18 3130-3137 GeneOrGeneProduct denotes insulin

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus D003920
T3 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T4 471-479 DiseaseOrPhenotypicFeature denotes diabetes DISEASE
T5 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T6 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T7 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T8 1371-1390 DiseaseOrPhenotypicFeature denotes insulin sensitivity D007333
T9 1430-1448 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T10 1979-1998 DiseaseOrPhenotypicFeature denotes insulin sensitivity D007333
T11 2153-2171 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T12 2377-2395 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T13 2965-2983 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T14 3130-3148 DiseaseOrPhenotypicFeature denotes insulin resistance D007333

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 1291-1295 GeneOrGeneProduct denotes MAIN
T2 1355-1369 GeneOrGeneProduct denotes insulin levels

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T2 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus 0005015
T3 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T4 471-479 DiseaseOrPhenotypicFeature denotes diabetes 0005015
T5 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T6 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T7 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder 0014092|0005487|0005090
T10 1379-1390 DiseaseOrPhenotypicFeature denotes sensitivity 0000605
T11 1499-1501 DiseaseOrPhenotypicFeature denotes SD 0011449
T12 1987-1998 DiseaseOrPhenotypicFeature denotes sensitivity 0000605

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus D003920
T3 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T4 471-479 DiseaseOrPhenotypicFeature denotes diabetes DISEASE
T5 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T6 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T7 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T8 1371-1390 DiseaseOrPhenotypicFeature denotes insulin sensitivity D007333
T9 1430-1448 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T10 1979-1998 DiseaseOrPhenotypicFeature denotes insulin sensitivity D007333
T11 2153-2171 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T12 2377-2395 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T13 2965-2983 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T14 3130-3148 DiseaseOrPhenotypicFeature denotes insulin resistance D007333

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus D003920
T3 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T4 471-479 DiseaseOrPhenotypicFeature denotes diabetes DISEASE
T5 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T6 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T7 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T8 1430-1448 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T9 2153-2171 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T10 2377-2395 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T11 2965-2983 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T12 3130-3148 DiseaseOrPhenotypicFeature denotes insulin resistance D007333

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 22-30 OrganismTaxon denotes patients
T2 262-270 OrganismTaxon denotes patients
T3 695-703 OrganismTaxon denotes patients

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 0-7 ChemicalEntity denotes Glucose http://purl.obolibrary.org/obo/CHEBI_42758|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T4 127-134 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T7 408-415 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T10 538-547 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T12 552-562 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T14 568-579 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T16 619-626 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T19 772-779 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T22 1069-1076 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T25 1221-1230 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T27 1232-1242 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T29 1247-1258 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T31 1329-1336 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T34 1454-1461 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T37 1599-1608 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T39 1633-1643 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T41 1665-1676 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T43 1764-1773 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T45 1774-1784 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T47 1785-1796 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T49 1835-1844 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T51 1849-1860 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T53 1889-1899 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T55 1904-1915 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T57 2043-2052 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T59 2053-2063 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T61 2064-2075 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T63 2105-2114 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T65 2119-2129 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T67 2217-2228 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T69 2230-2239 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T71 2243-2254 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T73 2279-2289 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T75 2293-2304 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T77 2462-2471 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T79 2472-2482 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T81 2483-2494 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T83 2497-2506 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T85 2510-2521 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T87 2547-2557 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T89 2561-2572 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T91 2649-2656 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T94 2696-2705 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T96 2706-2716 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T98 2717-2728 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T100 2767-2776 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T102 2781-2792 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T104 2822-2832 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T106 2837-2848 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T108 2902-2911 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T110 2917-2927 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T112 3002-3009 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T115 3038-3049 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T117 3084-3093 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T119 3098-3108 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T119 3098-3108 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T117 3084-3093 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T115 3038-3049 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T112 3002-3009 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T110 2917-2927 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T108 2902-2911 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T106 2837-2848 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T104 2822-2832 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T102 2781-2792 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T100 2767-2776 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T98 2717-2728 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T96 2706-2716 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T94 2696-2705 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T91 2649-2656 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T89 2561-2572 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T87 2547-2557 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T85 2510-2521 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T83 2497-2506 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T81 2483-2494 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T79 2472-2482 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T77 2462-2471 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T75 2293-2304 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T73 2279-2289 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T71 2243-2254 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T69 2230-2239 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T67 2217-2228 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T65 2119-2129 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T63 2105-2114 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T61 2064-2075 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T59 2053-2063 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T57 2043-2052 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T55 1904-1915 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T53 1889-1899 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T51 1849-1860 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T49 1835-1844 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T47 1785-1796 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T45 1774-1784 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T43 1764-1773 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T41 1665-1676 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T39 1633-1643 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T37 1599-1608 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T34 1454-1461 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T31 1329-1336 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T29 1247-1258 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T27 1232-1242 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T25 1221-1230 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T22 1069-1076 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T19 772-779 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T16 619-626 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T14 568-579 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T12 552-562 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T10 538-547 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T7 408-415 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T4 127-134 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T1 0-7 ChemicalEntity denotes Glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_42758
T2 1355-1369 GeneOrGeneProduct denotes insulin levels
T98068 1291-1295 GeneOrGeneProduct denotes MAIN
T51722 3130-3148 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T11 2965-2983 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T91158 2377-2395 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T9 2153-2171 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T8 1430-1448 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T8938 1144-1168 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T6 1127-1140 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T5 709-722 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T61508 471-479 DiseaseOrPhenotypicFeature denotes diabetes DISEASE
T3 276-289 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T78804 223-240 DiseaseOrPhenotypicFeature denotes diabetes mellitus D003920
T13934 36-49 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T97969 695-703 OrganismTaxon denotes patients
T15096 262-270 OrganismTaxon denotes patients
T7520 22-30 OrganismTaxon denotes patients